Lifeward

Battery-powered Walking System

Health Tech & Life Sciences
Public on NASDAQ on Sep 2014

Company Overview

Snapshot

Founded in June 2001, Lifeward operates with 11–50 employees and has raised a total of $257.92 million across 22 funding rounds from 12 investors. The company went public on NASDAQ in September 2014 and in July 2026, secured growth capital led by Oramed Pharmaceuticals.

Business overview

Lifeward is dedicated to innovating solutions for individuals with physical limitations or disabilities, focusing on empowering them through advanced technology. The company's portfolio includes groundbreaking products such as the ReWalk Exoskeleton and ReStore Exo-Suit. Operating within the Health Tech & Life Sciences sector, Lifeward serves markets across Europe, the United States, and Asia, specializing in medical devices, assistive devices, and digital healthcare solutions.

Strategic signal

In May 2026, Lifeward announced new ReWalk data presented at the ASIA 2026 Conference, showcasing a comprehensive longitudinal safety analysis for its powered exoskeleton. This presentation highlights the company's ongoing commitment to rigorous scientific validation and product safety, reinforcing investor confidence in the long-term efficacy and reliability of its core technology within the assistive devices market.

Company Intelligence Q&A

What was a significant recent financial event for Lifeward?
In July 2026, Lifeward secured growth capital with up to $11.2 million in strategic financing, led by Oramed Pharmaceuticals, to accelerate commercial expansion.
When did Lifeward go public?
Lifeward completed its Initial Public Offering (IPO) on NASDAQ in September 2014, raising $36 million with a valuation of $136 million.
What was Lifeward's most recent acquisition?
In August 2023, Lifeward acquired AlterG, a move aimed at enhancing its product portfolio and profitability.
What is the latest development regarding Medicare coverage for Lifeward's products?
In November 2023, Medicare proposed a preliminary reimbursement level for the ReWalk Personal Exoskeleton, a historic move that solidifies potential coverage for the device.
What was a key product milestone for ReWalk Robotics (now Lifeward) in 2016?
In September 2016, ReWalk Robotics achieved the milestone of 100 personal systems sold, demonstrating growing adoption of its exoskeleton technology.

External links